It’s been a busy week in pharmacy…
We started the week with a look at polypharmacy in senior Australians, with research led by Dr Amy Page showing a significant increase in the number of medicines taken by older people.
NAPSA has a new president: congratulations to Erin Cooper and the newly elected directors. And in another changing of the guard, Anthony While stepped down as CEO of TerryWhite Chemmart, with Duncan Phillips to succeed him.
We covered the topic of embedding pharmacists into aged care facilities, including the evidence given by Dr Janet Sluggett, NHMRC early career fellow at Monash University’s Centre for Medicine Use and Safety, to the Royal Commission into Aged Care; PSA said that it’s not a zero-sum approach, believing that embedding pharmacists is the answer to addressing medicine-related harm in aged care. The Guild’s Trent Twomey, however, has other thoughts.
Australians are being asked to be aware of the symptoms of meningococcal disease; Amcal and Jack Perkins teamed up again on diabetes awareness; and we looked at how pharmacists can help primary care physicians.
And pembrolizumab (Keytruda) became the first medicine to have additional indications registered on the ARTG via the TGA’s provisional approval pathway.